[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Polaryx Therapeutics Inc (PLYX)

Polaryx Therapeutics Inc (PLYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Polaryx Therapeutics Inc 140 EAST RIDGEWOOD AVENUE SUITE 415 SOUTH TOWER PARAMUS NJ 07652 USA

www.polaryx.com Employees: 11 P: 201-940-7236

Sector:

Medical

Description:

Polaryx Therapeutics Inc. is a clinical-stage biotechnology company focused on development, and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders. Polaryx Therapeutics Inc. is based in PARAMUS, NJ.

Key Statistics

Overview:

Market Capitalization, $K 103,181
Enterprise Value, $K 98,041
Shares Outstanding, K 49,846
Float, K 27,007
% Float 54.18%
Short Interest, K 257
Short Float 0.52%
Days to Cover 2.48
Short Volume Ratio 0.71
% of Insider Shareholders 45.82%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -8,990 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,380 K
EBIT, $ -9,270 K
EBITDA, $ -9,270 K

Growth:

1-Year Return -94.66%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.03 on 08/13/26
Next Earnings Date 11/12/26
Earnings Per Share ttm -0.08
EPS Growth vs. Prev Qtr 40.00%
EPS Growth vs. Prev Year -11.14%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

PLYX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 9.75
Book Value/Share 0.22
Interest Coverage -4.76
60-Month Beta N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.